ESC 365 - Differences in anticoagulation strategy and outcome in patients with atrial fibrillation according to renal function

EHRA Premium Access

Differences in anticoagulation strategy and outcome in patients with atrial fibrillation according to renal function

Session: Managing the thromboembolic risk in atrial fibrillation

Topic: Atrial Fibrillation - Epidemiology, Prognosis, Outcome

Event: EHRA 2018

Congress Presentation

Add to my library

6 more presentations in this session

Incidence of atrial arrhythmia and uptake of anticoagulation in stroke and non-stroke populations according to arrhythmia burden; a 7-year experience.

Speaker: Doctor P. Chousou (Cambridge, GB)

Relation of Nonsteroidal Anti-Inflammatory Drugs and Time in Therapeutic Range in Bleeding Risk in Atrial Fibrillation: the SPORTIF Trials

Speaker: Doctor M. Proietti (Milan, IT)

Incidence and predictors of left atrial appendage thrombus in patients treated with direct oral anticoagulants versus warfarin for non-valvular atrial fibrillation

Speaker: Doctor K. Minami (Utsunomiya, JP)

Left atrial stunning as a predictor of atrial fibrillation occurrence after cryptogenic stroke

Speaker: Doctor J. Farinha (Setubal, PT)

Indications for and outcome in patients undergoing left atrial appendage closure - Results of the Austrian LAAC Registry

Speaker: Mr D. Zweiker (Vienna, AT)

Access the full session

Managing the thromboembolic risk in atrial fibrillation

Speakers: Doctor P. Chousou, Doctor M. Proietti, Doctor K. Minami, Doctor J. Farinha, Mr D. Zweiker

About the event

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources